Friday, Jul 24, 2026 The claims desk. Receipts included. POWERED BY LENZ ↗
IsThis

HEALTH

The Claim

Ozempic and similar GLP-1 drugs have contributed to a reduction in United States obesity rates for the first time in decades.

Verified by Lenz ·

The Short Version

U.S. adult obesity rates have indeed declined modestly — from roughly 42.8% (2017–2018) to about 40.3% (2021–2023) per CDC data, with Gallup surveys showing a further drop to ~37% by 2025. This coincides with a dramatic surge in GLP-1 drug use (30+ million Americans by 2025). Experts widely identify GLP-1 drugs as a plausible contributing factor, but no study has confirmed a direct causal link at the population level. The decline is also uneven — rural obesity actually rose — and other factors like post-COVID behavioral changes haven't been ruled out.

Caveats

  • The causal link between GLP-1 drugs and the population-level obesity decline is not established — all major sources use hedged language like 'may explain' or 'could be playing a role,' not confirmed causation.
  • The obesity decline is modest and uneven: rural obesity rates actually increased during the same period, and children/teen obesity hit record highs, complicating the narrative of a broad national reversal.
  • The sharper decline figures (to ~37%) come from Gallup self-reported online surveys, which use different methodology than CDC clinical measurements (NHANES) — the two datasets are not directly comparable.

The Receipts

  1. GLP-1 Injectable Use Among Adults With Diagnosed Diabetes: United States, 2024 - CDC

    CDC

  2. US Obesity Rates Have Dropped, And GLP-1 Drugs May Explain Why - ScienceAlert

    ScienceAlert

  3. CDC finds record-high obesity rates for children, teens, as adults have slight decline - AHA

    AHA

  4. 6 facts about obesity and weight loss drugs in the U.S. - Pew Research Center

    Pew Research Center

  5. Obesity rate is declining as more Americans use weight loss drugs, survey finds - CBS News

    CBS News

  6. Weight-loss drugs could be key reason why US obesity rates falling, experts say

    The Guardian

  7. GLP-1 pills for weight loss are here. How will they change obesity care? | AAMC

    AAMC

  8. U.S. Obesity Rate Changes Differ for Rural and Urban Areas, as Well as Across Regions

    U.S. Department of Agriculture, Economic Research Service (USDA ERS)

  9. State of Obesity Report 2025 : Better Policies for a Healthier America - TFAH.org

    TFAH.org

  10. How Supply and Demand for Weight Loss Drugs is Playing Out in 2026 - J.P. Morgan

    J.P. Morgan

+ 5 more sources — see the full list on Lenz

Filed Under

GLP-1 drugsOzempicUnited States

More Fact Checks